Next Gen HSN1 – Precision Medicine for Early Stage Genetic Small Fiber Neuropathy

9 September 2021

Email *

Thank you!
Check your email to confirm your subscription.

Search for:

The MAYDAY Fund 
420 Lexington Avenue, Suite 331
 New York, NY 10170